A M M Eijsbouts

973 citations

17 papers · 738 indexed · h-index 14

Rheumatology top 2%
Immunology
Radiology, Nuclear Medicine and Imaging top 10%
Genetics top 10%
Hematology top 10%

Co-authors: Piet L. C. M. van Riel F.H.J. van den Hoogen Christian Enevold Klaus Bendtzen Timothy R. D. J. Radstake Morten Svenson Jaap Fransen Roland Laan
Topics: Rheumatoid Arthritis Research and Therapies (9 papers)Adrenal Hormones and Disorders (4 papers)Systemic Lupus Erythematosus Research (4 papers)
Cited by: Rheumatology Behavioral Neuroscience Immunology
Journals: PLoS ONE Annals of the Rheumatic Diseases British Journal of Clinical Pharmacology
Partner nations: Netherlands Denmark Ireland

In The Last Decade

A M M Eijsbouts

17 papers receiving 724 citations

Peers

Countries citing papers authored by A M M Eijsbouts

Since Specialization

Citations

This map shows the geographic impact of A M M Eijsbouts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A M M Eijsbouts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A M M Eijsbouts more than expected).

Fields of papers citing papers by A M M Eijsbouts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A M M Eijsbouts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A M M Eijsbouts. The network helps show where A M M Eijsbouts may publish in the future.

Co-authorship network of co-authors of A M M Eijsbouts

This figure shows the co-authorship network connecting the top 25 collaborators of A M M Eijsbouts. A scholar is included among the top collaborators of A M M Eijsbouts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A M M Eijsbouts. A M M Eijsbouts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Support needs for medication use and the suitability of eHealth technologies to address these needs: a focus group study of older patients with rheumatoid arthritis 2018 ·Patient Preference and Adherence ·Elke Mathijssen,Johanna E Vriezekolk,A M M Eijsbouts,F.H.J. van den Hoogen,Bart J. F. van den Bemt	17
2	An acceptance-oriented cognitive-behavioral therapy in multimodal rehabilitation: A pre-post test evaluation in highly distressed patients with rheumatic diseases 2013 ·Patient Education and Counseling ·Johanna E Vriezekolk,A M M Eijsbouts,W.G.J.M. van Lankveld,(unknown),Rinie Geenen,C.H.M. van den Ende	14
3	Validation Study of Existing Gene Expression Signatures for Anti-TNF Treatment in Patients with Rheumatoid Arthritis 2012 ·PLoS ONE ·Erik J. M. Toonen,Christian Gilissen,Barbara Franke,Wietske Kievit,A M M Eijsbouts,Alfons A den Broeder,Simon V. van Reijmersdal,Joris A. Veltman,Hans Scheffer,Timothy R. D. J. Radstake,Piet L. C. M. van Riel,Pilar Barrera,Marieke J. H. Coenen	49
4	Meta-analysis identified the TNFA -308G > A promoter polymorphism as a risk factor for disease severity in patients with rheumatoid arthritis 2012 ·Arthritis Research & Therapy ·Erik J. M. Toonen,Pilar Barrera,Jaap Fransen,Arjan P.M. de Brouwer,A M M Eijsbouts,Pierre Miossec,Hubert Marotte,Hans Scheffer,(unknown),Barbara Franke,Marieke J. H. Coenen	19
5	The coping flexibility questionnaire: development and initial validation in patients with chronic rheumatic diseases 2011 ·Rheumatology International ·Johanna E Vriezekolk,W.G.J.M. van Lankveld,A M M Eijsbouts,T. van Helmond,Rinie Geenen,C.H.M. van den Ende	42
6	Effects of naproxen and sulphasalazine or methotrexate on hypothalamic-pituitary-adrenal axis activity in patients with rheumatoid arthritis. 2011 ·PubMed ·A M M Eijsbouts,Marlies Kempers,F.H.J. van den Hoogen,Roland Laan,A. R. M. M. Hermus,(unknown),Fred C.G.J. Sweep,Leo B. A. Van De Putte	3
7	Can psychological interventions alter the physiological stress response of patients with rheumatoid arthritis 2011 ·(unknown),(unknown),Fred C.G.J. Sweep,Rogier Donders,A M M Eijsbouts,TRDJ Radstake,P.L. van Riel,Andrea W.M. Evers	1
8	Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis 2010 ·Arthritis Care & Research ·B J Radovits,Jaap Fransen,(unknown),A M M Eijsbouts,Piet L. C. M. van Riel,Roland Laan	104
9	Effect of naproxen on the hypothalamic–pituitary– adrenal axis in healthy volunteers 2008 ·British Journal of Clinical Pharmacology ·A M M Eijsbouts,Marlies Kempers,(unknown),Maria T. E. Hopman,F.H.J. van den Hoogen,(unknown),Ad R. Hermus,Fred C.G.J. Sweep,Leo B. A. Van De Putte	5
10	Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis 2008 ·Annals of the Rheumatic Diseases ·Timothy R. D. J. Radstake,Morten Svenson,A M M Eijsbouts,F.H.J. van den Hoogen,Christian Enevold,Piet L. C. M. van Riel,Klaus Bendtzen	311
11	The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis 2008 ·Annals of the Rheumatic Diseases ·Erik J. M. Toonen,Marieke J. H. Coenen,Wietske Kievit,Jaap Fransen,A M M Eijsbouts,Hans Scheffer,TRDJ Radstake,M.C.W. Creemers,(unknown),Piet L. C. M. van Riel,Barbara Franke,Pilar Barrera	35
12	Circulating levels of the chemokine CCL18 but not CXCL16 are elevated and correlate with disease activity in rheumatoid arthritis 2007 ·Annals of the Rheumatic Diseases ·Antoine W.T. van Lieshout,Jaap Fransen,Marcel Flendrie,A M M Eijsbouts,F.H.J. van den Hoogen,Piet L. C. M. van Riel,Timothy R. D. J. Radstake	25
13	Comment on the use of self‐reporting instruments to assess patients with rheumatoid arthritis: The longitudinal association between the DAS28 and the VAS general health 2006 ·Arthritis Care & Research ·Wietske Kievit,Paco M J Welsing,Eddy Adang,A M M Eijsbouts,Paul F. M. Krabbe,Piet L. C. M. van Riel	20
14	Hypothalamic-pituitary-adrenal axis activity in patients with rheumatoid arthritis. 2005 ·PubMed ·A M M Eijsbouts,F.H.J. van den Hoogen,(unknown),A. R. M. M. Hermus,Fred C.G.J. Sweep,L.B.A. van de Putte	48
15	Decreased prolactin response to hypoglycaemia in patients with rheumatoid arthritis: correlation with disease activity 2004 ·Annals of the Rheumatic Diseases ·A M M Eijsbouts,(unknown),(unknown),(unknown),(unknown),(unknown)	17
16	The role of the hypothalamic–pituitary–adrenal axis in rheumatoid arthritis 1999 ·Best Practice & Research Clinical Rheumatology ·A M M Eijsbouts,Evelyn P. Murphy	14
17	Undefined malabsorption syndrome with villous atrophy successfully reversed by treatment with cyclosporine. 1995 ·PubMed ·A M M Eijsbouts,Ben Witteman,(unknown),J.F.M. Fennis,(unknown),A.H.J. Naber,(unknown)	14

About A M M Eijsbouts

A M M Eijsbouts is a scholar working on Behavioral Neuroscience, Rheumatology and Family Practice, having authored 17 papers that have together received 738 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (9 papers), Adrenal Hormones and Disorders (4 papers) and Systemic Lupus Erythematosus Research (4 papers). The work is most often cited by research in Rheumatology (409 citations), Behavioral Neuroscience (36 citations) and Immunology (213 citations). A M M Eijsbouts has collaborated with scholars based in Netherlands, Denmark and Ireland. Frequent co-authors include Piet L. C. M. van Riel, F.H.J. van den Hoogen, Christian Enevold, Klaus Bendtzen, Timothy R. D. J. Radstake, Morten Svenson, Jaap Fransen, Roland Laan, B J Radovits and Johanna E Vriezekolk. Their work appears in journals such as PLoS ONE, Annals of the Rheumatic Diseases and British Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact